Abstract
Surveillance for infectious disease outbreak or for other processes should sometimes be implemented simultaneously on multiple sites to detect local events. Sick leave can be monitored accross companies to detect issues such as local outbreaks and identify companies-related issues as local spreading of infectious diseases or bad management practice. In this context, we proposed an adaptation of the Quasi-Poisson regression-based Farrington algorithm for multi-site surveillance. The proposed algorithm consists of a Negative-Binomial mixed effect regression with a new reweighting procedure to account for past outbreaks and increase sensitivity of the model. We perform a wide range simulations to assess the performance of the model in terms of False Positive Rate and Probability of Detection. We propose an application to sick leave rate in the context of COVID-19. The proposed algorithm provides good overall performance and opens up new opportunities for multi-site data surveillance.
Competing Interest Statement
Tom Duchemin is employee of Malakoff Humanis.
Funding Statement
Tom Duchemin's PhD is funded by Association Nationale de la Recherche et de la Technologie (grant number 2017/1517).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Unapplicable: the data used in this study areaggregated and completely anonymous and comes from an administrative database that can be used for our purposes.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, Tom Duchemin, upon reasonable request.
